Kala Pharmaceuticals (KALA) Competitor Comparison
We are evaluating the key criteria listed to compare Kala Pharmaceuticals (KALA) against its competitors in the Biotechnology industry.
Market Capitalization
330 / 368Gross Profits
125 / 278Total Revenue
288 / 300EBITDA
126 / 337Free Cashflow
140 / 352Quick Ratio
175 / 357Earnings per Share
345 / 359Dividend yield
0 / 6Total Cash
252 / 358Performance 3 years
306 / 368Performance 5 years
339 / 368Performance 10 years
333 / 368Linearity 3 years
298 / 368Linearity 5 years
168 / 368Linearity 10 years
251 / 367Total Rank
171 / 368Dividend Rank
176 / 368Valuation Rank
153 / 368Piotroski Rank
219 / 368Muliplier Rank
42 / 368Market Capitalization - KALA ranking 330 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.